Wordt geladen...
Absorption of riociguat (BAY 63-2521): bioavailability, food effects, and dose proportionality
Abstract. Riociguat (BAY 63-2521) is the first member of a novel class of compounds, the soluble guanylate cyclase (sGC) stimulators. Riociguat has a dual mode of action: it sensitizes sGC to endogenous nitric oxide (NO) and stimulates sGC independent of NO availability. To characterize the biopharm...
Bewaard in:
| Gepubliceerd in: | Pulm Circ |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
University of Chicago Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809663/ https://ncbi.nlm.nih.gov/pubmed/27096084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685018 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|